CNVIF — Conavi Medical Balance Sheet
0.000.00%
Last trade - 00:00- $29.05m
- $41.75m
- CA$9.12m
Annual balance sheet for Conavi Medical, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 32.4 | 40.8 | 4.46 | 9.99 | 5.84 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.091 | 10.5 | 0 | — | 0.672 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 34.3 | 55.2 | 6.82 | 11.5 | 8.27 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.42 | 2.07 | 0 | — | 2.02 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 38 | 59.7 | 9.65 | 11.6 | 12.4 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 54.6 | 13.8 | 12.1 | 4.13 | 8.21 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 55.6 | 15.1 | 13.9 | 5.27 | 30.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -17.6 | 44.6 | -4.29 | 6.34 | -18 |
| Total Liabilities & Shareholders' Equity | 38 | 59.7 | 9.65 | 11.6 | 12.4 |
| Total Common Shares Outstanding |